Aelan Cell Technologies � Alzheimer's biomarker

Aelan Cell Technologies, founded by Dr. Victoria Lunyak, is engaged in the research, discovery, development and commercialization of innovative biomedical technologies for the advancement of human health and longevity. On July 6, 2016 Aelan Cell Technologies announced they were developing a novel biomarker for Alzheimer’s disease. Aelan also has an interest in developing a range of stem cell technologies.